MycoTechnology, the developer of a mushroom-based vegan protein, secured the capital in a round co-led by Bunge that included Kellogg and Continental Grain.
US-based food technology developer MycoTechnology has closed a $35m series B round co-led by Bunge Ventures, the corporate venture capital unit of agribusiness and food company Bunge.
S2G and Emerson Collective co-led the round, which also featured agribusiness Continental Grain and Eighteen94 Capital, the investment arm of packaged food producer Kellogg Company.
VC firm Seventure Partners’ Health for Life Capital fund, Middleland Capital, Tao Capital Partners, GreatPoint Ventures, Closed Loop Capital and Windy City also participated in the transaction, which…
